1. Nat. Rev. Cardiol. doi:10.1038/nrcardio.2016.96
Figure 4 Meta-analysis of randomized trials comparing the effect of percutaneous left ventricular assist devices (LVAD) versus the intra-aortic balloon pump (IABP) on 30‑day mortality and haemodynamics
Figure 4 | Meta-analysis of randomized trials comparing the effect of percutaneous left ventricular assist devices (LVAD) versus the intra-aortic balloon pump (IABP) on 30-day mortality and haemodynamics. Despite clear improvements in haemodynamics with percutaneous LVAD compared with IABP, 30-day mortality appeared to be similar. However, these trials were not powered to test for mortality differences. Random effect models were used for meta-analysis. For the top three panels, weighted mean differences with 95% confidence intervals are presented on the right of the figure. For the bottom panel, relative risks with 95% confidence intervals are presented on the right of the figure. Modified from Cheng, M. et al. Percutaneous left ventricular assist devices versus intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur. Heart J. 2009; 30 (17): 2102–2108, with permission from Oxford University Press.
Modified from Cheng, M. et al. Percutaneous left ventricular assist devices versus intra-aortic balloon pump counterpulsation for treatment
of cardiogenic shock:a meta-analysis of controlled trials. Eur. Heart J. 2009; 30 (17): 2102–2108, with permission from Oxford University Press
Reyentovich, A. et al. (2016) Management of refractory cardiogenic shock
Nat. Rev. Cardiol. doi: /nrcardio